Drug profile · INN
escitalopram oxalate
ESCITALOPRAM OXALATE
escitalopram oxalate (ESCITALOPRAM OXALATE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — escitalopram oxalate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 16
- Data quality
- 0.89
Quick answer
escitalopram oxalate (ESCITALOPRAM OXALATE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent serotonin transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is escitalopram oxalate?
escitalopram oxalate (ESCITALOPRAM OXALATE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for escitalopram oxalate?
ESCITALOPRAM OXALATE is a marketed brand name for escitalopram oxalate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of escitalopram oxalate?
escitalopram oxalate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.